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• The New Designer Psychotropic 
Drugs 









 Designer Drugs: 
 Synthetically changed natural substances 
 Completely designed molecular structures 
 Psychotropic effects   
 New Designer Psychotropic Drugs: 
  Drug alternatives  
  Optimized effects of already existing drugs 
 Higher binding affinity with CB1, greater potency and adverse 
effects and longer duration of action 
  Not covered in most countries by controlled substance      
statutes  
 avoid detection and legal consequences 
 “Spice” drugs (smoking mixtures, herbal mixtures), bath 
salts, tablets form, on the recreational drug use market 
Families of the compounds 
Phenylalkylamines 
• Beta-keto (mephedrone, butylone (bk-MBDB), 
methylone (bk-MDMA) 
Piperazines 
• Phenylpiperazine (DCPP, mCPP, MeOPP, pCPP, 
TFMPP) 
• Benzylpiprazine (BZP, MBZP, DBZP, MDBZP) 
Synthetic Cannabinoids   
• JWH cannabinoids (John W. Huffman), (e.g. 
JWH 018, JWH 073 aminoalkylindoles series 
and more than 400 cannabinoids) 
• CP47, 497 (From Pfizer, cyclohexylphenol 
series) (analog CP47,497 and homologue 
C6,C7,C8,C9)  
Pyrrolidinophenones 
• Derivatives (a-PVP, MPPP, MPHP, MOPPP, 
MDPPP) 
A new class of emerging contaminants  
 Not currently covered by existing water quality 
regulations 
 Rarely investigated  
 Newly identified or previously unrecognized 
 Lack of environmental data 
 Lack of analytical methods in wastewater 
 Large volume of consumption and production 
 Potential threats to ecosystems and human (limited 
information)   
Entry to the aquatic environment 






























LC- (QqQ) MS/MS –ESI (+/-) 
Thermo Scientific Quantum Access 

























Rise in notifications 
of NPDs usage in 
Europe (EMCDDA 2013) 
Cause of possible 
toxicological effects 










14 per year 
in 2005 to 
73 in 2012 
Optimization of MS/MS 








































































Sheath gas:  
30 a.u.  








Spray Voltage:  
2500 V 
Sheath gas:  
20 a.u.  




Optimization of HPLC 
Comparison of Stationary phase 
HSS XSelect Τ3 - C18  
(100 mm x 2.1 mm, 2.5 μm, Waters) 
Atlantis Τ3 - C18  
(100 mm x 2.1 mm, 3.0 μm, Waters) 
Pentafluorophenyl (PFP)  
       (50 mm x 2.1 mm, 1.7 μm, Phenomenex) 
Peak area & shape 
Retention time 
Resolution 
Optimization of HPLC 



















Optimization of HPLC 
Comparison of Stationary phase 
RT: 0.00 - 30.00







































20.6013.51 27.973.97 17.7314.084.67 24.6823.6412.775.98 9.190.60
NL:
1.26E7




RT: 0.00 - 30.00










































17.92 23.2422.05 26.8924.24 27.771.00
NL:
1.04E7
TIC  MS 
std_100ppb
_test1_PFP
RT: 0.00 - 30.00








































6.63 17.1210.84 25.5420.75 26.1825.220.74
NL:
9.31E6





XSelect T3 and PFP 
non Polar compounds 
 Atlantis T3 and PFP 
 C18 columns: presented peak 
asymmetry (polar compounds) and do 
not provide good separation. 
 PFP:  
1. Higher sensitivity and 
resolution 
2. More symmetric peaks for polar 
compounds containing –NH2 or –
NH- groups  
XSelect-T3, HSS 
Atlantis-T3 PFP 
Optimization of HPLC 








0.00 60 40 100 
3.00 60 40 150 
15.00 0 100 100 
25.00 0 100 100 
25.50 60 40 100 








0.00 90 10 100 
3.00 90 10 100 
8.00 90 10 100 
CP47, 497 
Positive Ionization mode 
Optimization of HPLC 
Effect of the organic modifier (F.A.) 
RT: 0.00 - 30.00






































































AA: 9603 RT: 19.50
AA: 7214
RT: 14.33
AA: 6833 RT: 20.42
AA: 3647
RT: 9.18






















RT: 0.00 - 30.00

















































































































RT: 0.00 - 30.00













































































































RT: 0.0  - 30.00

































































































TIC 0.01 FA% 
TIC 0.05 FA% 
TIC 0.1 FA% 

















RT: 0.00 - 30.00




















































































28.631.86 2.23 7.115.51 9.26 18.2711.00 14.2712.54 15.76
NL: 7.68E4
Base Peak m/z= 
118.60-119.60 F: + c ESI SRM 
ms2 218.100 
[118.900-119.300, 




Base Peak m/z= 
146.50-147.50 F: + c ESI SRM 
ms2 218.100 
[118.900-119.300, 
146.800-147.200]  MS 
STD_NEW_DRUGS_50ppb_2
_001FA
RT: 0.00 - 30.00






































































15.07 16.353.11 5.08 5.92 17.91 24.90 28.1621.258.28 9.402.79 23.06 26.7211.610.54
NL: 3.37E5
Base Peak m/z= 
118.60-119.60 F: + c ESI SRM 
ms2 218.100 
[118.900-119.300, 




Base Peak m/z= 
146.50-147.50 F: + c ESI SRM 
ms2 218.100 
[118.900-119.300, 









RT: 0.00 - 30.00



































































13.22 14.39 16.0310.196.47 18.54 20.458.235.810.33 23.273.35 29.1527.1524.80
NL: 4.58E5
Base Peak m/z= 
118.60-119.60 F: + c ESI SRM 
ms2 218.100 
[118.900-119.300, 




Base Peak m/z= 
146.50-147.50 F: + c ESI SRM 
ms2 218.100 
[118.900-119.300, 
146.800-147.200]  MS 
STD_NEW_DRUGS_50ppb_2
_01FA
RT: 0.00 - 30.00

































































12.71 14.27 16.24 28.954.74 20.037.786.223.892.37 21.96 23.52 26.42
NL: 4.73E5
Base Peak m/z= 
118.60-119.60 F: + c ESI SRM 
ms2 218.100 
[118.900-119.300, 




Base Peak m/z= 
146.50-147.50 F: + c ESI SRM 
ms2 218.100 
[118.900-119.300, 









RT: 0.00 - 30.00






















































































































13.15 14.46 16.553.06 25.180.92 22.34 28.3027.1721.405.20 5.84 19.057.62
NL: 1.76E5
Base Peak m/z= 90.70-91.70 
F: + c ESI SRM ms2 177.100 
[65.100-65.500, 




Base Peak m/z= 64.80-65.80 
F: + c ESI SRM ms2 177.100 
[65.100-65.500, 




Base Peak m/z= 97.70-98.70 
F: + c ESI SRM ms2 184.100 
[70.100-70.500, 




Base Peak m/z= 69.80-70.80 
F: + c ESI SRM ms2 184.100 
[70.100-70.500, 
98.000-98.400]  MS 
STD_NEW_DRUGS_50ppb_
2_001FA
RT: 0.  - 30.00






































































































3.46 4.070.59 26.829.977.24 13.05 19.148.56 15.48 29.6925.2817.93 20.85 22.89
NL: 8.08E5
Base Peak m/z= 
90.70-91.70 F: + c ESI SRM 
ms2 177.100 
[65.100-65.500, 




Base Peak m/z= 
64.80-65.80 F: + c ESI SRM 
ms2 177.100 
[65.100-65.500, 




Base Peak m/z= 
97.70-98.70 F: + c ESI SRM 
ms2 184.100 
[70.100-70.500, 




Base Peak m/z= 
69.80-70.80 F: + c ESI SRM 
ms2 184.100 
[70.100-70.500, 







Optimization of SPE 
Comparison of different cartridges  
1. Strata X (Phenomenex) 
 
 
2. Strata XC (Phenomenex) 
 
 
3. Isolute C18 (EC) (Biotage) 
 
 
4. Double SPE (C18 (EC)- 
Strata XC 
 
5. ATOLL XC (Interchim) 
 
6. Lichrolut EN (bottom)- C18 
(top) (Merck) 
 
7. Lichrolut EN (Merck) 
 
 
8. PolyClean 2H (Interchim) 
 
 
9. Lichrolute TSC (Merck) 
 
Optimization of SPE  
1. Wastewater samples were 
filtered on Glass fiber filters  
2. 50 mL of filtrated sample were 
adjusted at a value of pH 2.5 
with HCl (1 M) 
3. Internal deuterated standards of 
the compounds were added to 
all samples 
4. SPE  
Reconstitution : 
500 μL of 60% MeOH 
and 40% ultra 
purified water with 
0.05% v/v formic acid 
LC-MS/MS 



























ISOLUTE C18 (EC) 
(Biotage) 
Double SPE (C18 (EC)-
Strata XC) 
ATOLL XC (Interchim) 
Lichrolut SCX (Merck) 



















































Cartridge EN - Different elution solvents 
Lichrolut EN (Merck)_MeOH 
Lichrolut EN 
(Merck)_MeOH/Ethylacetate (1:1) 
Lichrolut EN (Merck)_Ethylacetate 
Lichrolut EN (Merck)_DCM/Hexane 
(4:1) 
Lichrolut EN (Merck)_MeOH after 
MeOH/Ethyl. 
Lichrolut EN (Merck)_MeOH after 
Ethylacetate 




















Cartridge PolyClean 2H - Different elution 
solvents Poly Cean 2H 
(Interchim)_MeOH 
Poly Cean 2H 
(Interchim)_MeOH after 
DCM/Hexane (4:1) 
Poly Cean 2H 
(Interchim)_MeOH after 
ΜeOH/DCM (1:1) 
Poly Cean 2H 
(Interchim)_Acetonitrile 
Poly Cean 2H 
(Interchim)_MeOH after 
Ethylacetate 








Optimization of SPE~FINAL 
SOLVENTS 
Conditioning 6 ml methanol 
(under gravity) 
Equilibration  6 ml H2O (pH=2.5, HCl) 
(under gravity) 
Load  50 ml sample 
Wash 5 ml H2O (pH=2.5, HCl) 
 
Vacuum  30 min  
 
Elute  4 mL (2 x 2 mL MeOH) 
8 mL (4 x 2 mL) 
Methanol/ Ethyl acetate 
(50:50) 
PolyClean 2H 
Spherical Pure Mixed 













JWH-018 0.5-80 0.9994 0.20 0.62 
JWH-073 0.5-80 0.9991 0.28 0.86 
JWH-210 0.5-80 0.9995 0.04 0.14 
JWH-122 0.5-80 0.9992 0.05 0.16 
JWH-250 0.5-80 0.9996 0.23 0.71 
Mephedrone 0.5-80 0.9995 0.18 0.53 
BZP 0.5-80 0.9996 0.09 0.28 
MPPP 0.5-80 0.9997 0.09 0.28 
a-PVP 0.5-80 0.9994 0.07 0.22 
CP47,497 1-80 0.9995 0.04 0.12 
Instrumental quality parameters of the HPLC-ESI-MS/MS method 
for the analysis of NPDs. 
Method VALIDATION 
Conc. (ng/L) 












Influent wastewater  
JWH-018 10 65±9 800 65±10 -54 0.8 2.4 
JWH-073 10 60±9 800 61±9 -61 1.4 4.1 
JWH-210 10 69±9 800 73±11 -23 1.1 3.2 
JWH-122 10 60±4 800 67±10 -45 1.4 4.4 
JWH-250 10 54±10 800 69±9 -64 1.2 3.6 
Mephedrone 10 101±1 800 95±6 -63 0.8 2.5 
BZP 10 43±10 800 61±9 -85 3.7 11.3 
MPPP 10 109±4 800 97±7 -60 0.5 1.5 
a-PVP 10 96±2 800 103±8 -59 0.8 2.3 
CP47,497 10 120±3 800 99±6 -42 37 111 
Effluent wastewater  
JWH-018 10 44±8 800 50±6 -45 0.7 2.0 
JWH-073 10 44±9 800 51±5 -32 1.2 3.8 
JWH-210 10 40±7 800 51±9 -33 0.5 1.5 
JWH-122 10 40±9 800 57±9 -50 0.3 0.9 
JWH-250 10 46±6 800 61±8 -23 0.1 0.4 
Mephedrone 10 102±7 800 99±6 -35 0.6 1.8 
BZP 10 39±9 800 58±13 -43 4.8 14.4 
MPPP 10 98±9 800 98±11 -19 0.4 1.3 
a-PVP 10 98±4 800 102±8 -25 0.4 1.1 
CP47,497 10 78±9 800 91±10 -20 24 74 
Matrix Recovery MLOD  MLOQ 
Effluent 
wastewater 
50 – 102 % 0.1 –24 ng/L 0.4 – 74 ng/L 
Influent 
wastewater 
61 – 103 % 0.5 – 37 ng/L 1.5 –111 ng/L 
Application in real wastewater  
7 days,  

































Wastewater Samples from  
WWTP Santorini   
Santorini 
(Fira) 
Grab samples  
    22/07/2013 - 28/07/2013 
 
 Population: 10500 inhabitants 
 Flow rate: 1500 m3/day 
7 days,  
July 2013 
IWW 
Wastewater Samples from  














Frequency of detection  RANGES: 
•BZP → 16.7 -  47.4 ng/L 
•Mephedrone → 2.3 – 20.9 ng/L 
•MPPP → 0.8 – 1.3 ng/L 
•CP47→ 179 – 1469 ng/L 
•JWH 122→ <LOD – 2.3 ng/L 
•JWH 210→ <LOD – 3.5 ng/L 
Wastewater Samples from  
WWTP Santorini   

























































Wastewater Samples from  





Santorini (grab samples) 
5 influent 


















FIRA 1500 10500 same same 
KARTERADOS 900 3150 same same 
EMPORIO 600 3000 same same 
IA 700 6000 same same 
Wastewater Samples from  







































































Wastewater Samples from  




































Wastewater Samples from  
WWTP ATHENS  
Two  sampling campaigns in the WWTP of Athens, Greece 
  
March 2013 (7 consecutive days) 
March 2014 (7 consecutive days) 
 










Wastewater Samples from  
















































Wastewater Samples from  










































Wastewater Samples from  














































































Wastewater Samples from  















































































Wastewater Samples from  
Comparison 2013-2014 (trends) 
























Wastewater Samples from  









Wastewater Samples from  



























































CP47, 497 on Tuesday 
Wastewater Samples from  
WWTP of Athens  
24:00  22:00 20:00 18:00 16:00 14:00 12:00 10:00 8:00 6:00 4:00 2:00 
Tuesday (11/03/2014) 
Wastewater Samples from  
WWTP of Athens  
CONCLUSIONS 
  Development and validation of a novel method for new designer drugs in 
wastewater by LC-MS/MS  
 
 Investigation of their occurrence in a WWTP in Santorini Island 
 
 CP47, mppp and JWH 122/210 were detected for the first time in influent 
wastewater 
 
 6 out of the 10 compounds were detected at least in one day, whereas 
mephedrone, bzp,cp47 and mppp were detected all days in Santorini   
 
 Not any special trend among the days 
 
 The most ubiquitous compounds in influents of all WWTPs in both 
Santorini and Athens were CP47 and BZP. BZP was removed completely, 
whereas CP47 was partially removed.  
 
  JWH compounds were detected at slightly higher concentrations in 
effluents. 
OUTLINE 
Contact information: vborova@chem.uoa.gr 
                                  ntho@chem.uoa.gr   
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